HAVCR2 and Cirrhosis: Another potential therapeutic strategy to treat neutrophil dysfunction in cirrhosis may be the inhibition of PD1 (programmed cell death 1) and TIM3 (T-cell immunoglobulin and mucin domain-containing protein 3) receptors, which mediate immunosuppression.